F
Falk Rohrbach
Researcher at University of Bonn
Publications - 13
Citations - 1161
Falk Rohrbach is an academic researcher from University of Bonn. The author has contributed to research in topics: Aptamer & Systematic evolution of ligands by exponential enrichment. The author has an hindex of 9, co-authored 13 publications receiving 1035 citations. Previous affiliations of Falk Rohrbach include Goethe University Frankfurt & Novartis.
Papers
More filters
Journal ArticleDOI
Light-Controlled Tools
TL;DR: This Review will focus on developments over the last six years and includes discussions on the underlying technologies as well as their applications.
Journal ArticleDOI
Label-free impedimetric aptasensor for lysozyme detection based on carbon nanotube-modified screen-printed electrodes.
TL;DR: The direct electrochemical detection of aptamer-protein interactions, namely between a DNA aptamer and lysozyme (LYS) based on electrochemical impedance spectroscopy (EIS) technique, provides a means for the label-free, concentration-dependent, and selective detection of ly sozyme.
Journal ArticleDOI
Light‐Controlled Tools
TL;DR: Light is an ideal external trigger: it is highly selective and if applied correctly also harmless as discussed by the authors, it can be generated and manipulated with well-established techniques, and many ways exist to apply light to living systems.
Journal ArticleDOI
Profiling of Active Thrombin in Human Blood by Supramolecular Complexes
Jens Müller,Tobias Becher,Jennifer Braunstein,P. Berdel,Sascha Gravius,Falk Rohrbach,Johannes Oldenburg,Günter Mayer,Bernd Pötzsch +8 more
Journal ArticleDOI
Monitoring of plasma levels of activated protein C using a clinically applicable oligonucleotide-based enzyme capture assay
Jens Müller,Max J. Friedrich,Tobias Becher,J. Braunstein,Thomas S. Kupper,P. Berdel,Sascha Gravius,Falk Rohrbach,Johannes Oldenburg,Günter Mayer,Bernd Pötzsch +10 more
TL;DR: The development and validation of a technique that allows the measurement of APC plasma levels under practical laboratory conditions and a turn‐around time from blood sampling to generation of test results of < 7 h, the APC–OECA platform allows sensitive and rapid determination of circulating APC levels under pathological conditions.